Specifically, clinical subgroup analysis demonstrated that the N1 + N2 group with lymph node metastasis, M1 group with distant metastasis, and III + IV tumor stage group showed higher NAT10 expression levels, implying that NAT10 can regulate CRC proliferation and metastasis (Fig. S1E). The gene discussed is NAT10; the disease is colorectal carcinoma.